Thymosin Alpha-1

What Thymosin Alpha-1 is, structurally

Thymosin Alpha-1 is a peptide of twenty-eight residues, and the product page states that length.

The formula is unusually informative here. Of thirty-three nitrogens, twenty-eight are spoken for by backbone amides, leaving five on side chains. Of fifty-five oxygens, twenty-nine belong to the backbone carbonyls and the C-terminal acid, and one to the N-terminal acetyl group the product page describes, leaving twenty-five. Twenty-five side-chain oxygens against five side-chain nitrogens is a strongly acidic composition: many carboxyl and hydroxyl side chains, very few basic ones.

That acetyl group matters beyond the oxygen count. Capping the N-terminus removes the free alpha-amino group, and with it the positive charge an unmodified peptide carries there, pushing an already acidic molecule further toward net negative.

That ratio drives most of the handling. A peptide built this way carries substantial net negative charge at neutral pH and a low isoelectric point, and the consequence runs against a common bench habit. Peptides that dissolve reluctantly are often coaxed with a drop of dilute acetic acid, which works where the isoelectric point sits high. On an acidic peptide it does the opposite: lowering the pH moves the solution toward the point of minimum net charge, which is the point of minimum solubility. Neutral water is the better starting position, and a faintly alkaline buffer a more sensible second attempt.

There is no sulfur in the formula. That closes several routes at once: no cysteine and so no disulfide to reduce or scramble, no free thiol to oxidise, no methionine thioether to turn over. No reducing agent is called for.

Reconstitution and handling

Sterile water is the default solvent, and here it is also the better one, for the reason given above. Where a buffer is wanted, neutral to slightly alkaline assay buffers suit an acidic peptide well.

Add diluent down the inside wall of the vial, swirl gently, and let the solution clarify. Vortexing introduces foam without dissolving anything faster.

Adsorptive loss deserves the usual allowance at low concentration, with low-protein-binding tubes reducing it. A strongly negative peptide has little affinity for ordinary glass, itself negatively charged, but will bind cationic surfaces, so amine-coated plasticware is the wrong choice.

This is laboratory preparation chemistry, not dosing, administration, or protocol guidance of any kind.

Storage and stability

Store the lyophilized powder at -20 degrees C, sealed, desiccated and protected from light, and let a cold vial warm before opening. Reconstituted, hold at 2 to 8 degrees C, or aliquot and freeze rather than thawing repeatedly.

The five side-chain nitrogens are the ones to watch. Some sit on basic residues, but asparagine and glutamine also carry side-chain nitrogen, and both deamidate to the corresponding acids. On a peptide already this acidic the change compounds itself, since each event removes an amide and adds a carboxyl. The reaction needs water, so the dry solid is largely protected and solutions are not, and warmth and alkaline pH accelerate it. Cold, dry, near-neutral storage is the control.

Without a sequence on file this page will not name which positions carry that liability.

These are storage conditions for the material, not dosing or administration guidance.

How Thymosin Alpha-1 is tested

Reversed-phase HPLC establishes chromatographic purity as area percent. The low carbon-to-residue ratio points to little aromatic content, so detection should be assumed to sit near 214 nm. Standard acidic mobile phases still suit the analysis even though acid is unhelpful for dissolution, since trifluoroacetic acid protonates the carboxylates and improves retention and peak shape.

The blocked N-terminus carries one analytical consequence. Edman degradation requires a free alpha-amino group to attack, so it cannot sequence this peptide, and sequence confirmation must come from mass spectrometry instead.

Area percent is a chromatographic measure, not peptide content by weight. Solid-phase synthesis delivers a salt, and on an acidic peptide the counter-ion burden is real.

Mass spectrometry confirms identity against the expected weight, and one arithmetic point is worth stating plainly. The quoted 3108.31 is the average mass; the monoisotopic mass of the same formula is 3106.50, about 1.81 units lower, a gap wider than the roughly one unit a deamidation adds. A high-resolution instrument reporting monoisotopic mass will therefore read low against the label for ordinary reasons, and should not be taken for degradation.

These describe general methodology, not a claim about any particular batch.

Handling FAQ

The peptide is slow to dissolve. Should acid be added? Not as a first move. The composition is strongly acidic, so the isoelectric point is low and adding acid drives the solution toward minimum solubility rather than away from it. Neutral water and patience are the better approach, with a mildly alkaline buffer as the second attempt.

Why does the mass spectrometry result come in below 3108.31? Most often because the instrument is reporting monoisotopic mass, which for this formula is 3106.50. The 1.81 unit difference is a property of the formula, not a defect in the material.

Full specifications for Thymosin Alpha-1.